Unizony, S., Arias-Urdaneta, L., Miloslavsky, E., Arvikar, S., Khosroshahi, A., Keroack, B., Stone, J.R. and Stone, J.H. (2012) Tocilizumab for the Treatment of Large-Vessel Vasculitis (Giant Cell Arteritis, Takayasu Arteritis) and Polymyalgia Rheumatica. Arthritis Care & Research, 64, 1720-1729. http://dx.doi.org/10.1002/acr.21750

has been cited by the following article:

• TITLE: The Efficacy of Tocilizumab for Takayasu Arteritis: Review of the Literatures

  AUTHORS: Nesibe Karahan Yeşil, Hatice Şahin, Metin Işik, Ziyaeddin Aktop, İsmail Doğan, Ali Erdem Baki

  KEYWORDS: Takayasu Arteritis, Tocilizumab, Corticosteroid

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.5 No.4, November 2, 2015

  ABSTRACT: Takayasu arteritis is a large vessel vasculitis of the young women with giant cells and granuloma formation. The diagnosis and management of the disease are really not so easy because of the insidious onset and the difficulties in assessment of disease activity. Nearly 60% of the patients are corticosteroid resistant or dependent and relapses are very frequent during taper of the dose [1]. The novel biologic agents as Anti-TNF, Rutiximab and Tocilizumab provide acceptable response rates with low toxicity. Herein, we reviewed the efficacy of Tocilizumab in Takayasu arteritis.